BNP Paribas Financial Markets’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-989
| Closed | -$1.34K | – | 3712 |
|
|
2021
Q4 | $1.34K | Buy |
989
+630
| +175% | +$850 | ﹤0.01% | 3377 |
|
|
2021
Q3 | $1.05K | Hold |
359
| – | – | ﹤0.01% | 3265 |
|
|
2021
Q2 | $1.25K | Sell |
359
-1,726
| -83% | -$6.02K | ﹤0.01% | 3327 |
|
|
2021
Q1 | $7.13K | Sell |
2,085
-1,044
| -33% | -$3.57K | ﹤0.01% | 3280 |
|
|
2020
Q4 | $60.1K | Sell |
3,129
-38
| -1% | -$730 | ﹤0.01% | 2814 |
|
|
2020
Q3 | $42.5K | Buy |
3,167
+2,623
| +482% | +$35.2K | ﹤0.01% | 2932 |
|
|
2020
Q2 | $23K | Sell |
544
-2,462
| -82% | -$104K | ﹤0.01% | 2710 |
|
|
2020
Q1 | $83K | Buy |
3,006
+1,299
| +76% | +$35.9K | ﹤0.01% | 2697 |
|
|
2019
Q4 | $55.4K | Buy |
1,707
+83
| +5% | +$2.69K | ﹤0.01% | 2933 |
|
|
2019
Q3 | $42.3K | Buy |
1,624
+770
| +90% | +$20K | ﹤0.01% | 2946 |
|
|
2019
Q2 | $31.3K | Sell |
854
-588
| -41% | -$21.6K | ﹤0.01% | 3086 |
|
|
2019
Q1 | $31.9K | Buy |
1,442
+1,330
| +1,188% | +$29.4K | ﹤0.01% | 3157 |
|
|
2018
Q4 | $1.58K | Sell |
112
-102
| -48% | -$1.44K | ﹤0.01% | 3161 |
|
|
2018
Q3 | $4.15K | Hold |
214
| – | – | ﹤0.01% | 3458 |
|
|
2018
Q2 | $4.73K | Sell |
214
-1,015
| -83% | -$22.4K | ﹤0.01% | 3467 |
|
|
2018
Q1 | $26K | Buy |
+1,229
| New | +$26K | ﹤0.01% | 3267 |
|